Can Long-Term Results Following Balloon Angioplasty Be the "Crystal Ball" to Predict Outcome Following Bioresorbable Vascular Scaffolds?

被引:8
作者
Colombo, Antonio [1 ]
Latib, Azeem
机构
[1] EMO GVM Ctr Cuore Columbus, I-20145 Milan, Italy
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2012年 / 1卷 / 05期
关键词
editorials; bioresorbable vascular scaffold; coronary stent; drug-eluting stent; late stent thrombosis; stent thrombosis; CORONARY STENT SYSTEM; ELUTING STENTS; ARTERY-DISEASE; BARE-METAL; EVEROLIMUS; ABSORB; 2ND-GENERATION; LESIONS;
D O I
10.1161/JAHA.112.005272
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 17 条
[1]   Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? [J].
Brugaletta, Salvatore ;
Heo, Jung Ho ;
Garcia-Garcia, Hector M. ;
Farooq, Vasim ;
van Geuns, Robert Jan ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Smits, Pieter C. ;
Koolen, Jacques ;
McClean, Dougal ;
Dorange, Cecile ;
Veldhof, Susan ;
Rapoza, Richard ;
Onuma, Yoshinobu ;
Bruining, Nico ;
Ormiston, John A. ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2012, 33 (11) :1325-1333
[2]   Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque? [J].
Brugaletta, Salvatore ;
Radu, Maria D. ;
Garcia-Garcia, Hector M. ;
Heo, Jung Ho ;
Farooq, Vasim ;
Girasis, Chrysafios ;
van Geuns, Robert-Jan ;
Thuesen, Leif ;
McClean, Dougal ;
Chevalier, Bernard ;
Windecker, Stephan ;
Koolen, Jacques ;
Rapoza, Richard ;
Miquel-Hebert, Karine ;
Ormiston, John ;
Serruys, Patrick W. .
ATHEROSCLEROSIS, 2012, 221 (01) :106-112
[4]   Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials [J].
Caixeta, Adriano ;
Lansky, Alexandra J. ;
Serruys, Patrick W. ;
Hermiller, James B. ;
Ruygrok, Peter ;
Onuma, Yoshinobu ;
Gordon, Paul ;
Yaqub, Manejeh ;
Miquel-Hebert, Karine ;
Veldhof, Susan ;
Sood, Poornima ;
Su, Xiaolu ;
Jonnavithula, Lalitha ;
Sudhir, Krishnankutty ;
Stone, Gregg W. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) :1220-1228
[5]   The Magic of Disappearing Stents [J].
Dauerman, Harold L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (15) :1589-1591
[6]  
Di Mario Carlo, 2009, EuroIntervention, V5 Suppl F, pF103, DOI 10.4244/EIJV5IFA18
[7]   Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial [J].
Dudek, Dariusz ;
Onuma, Yoshinobu ;
Ormiston, John A. ;
Thuesen, Leif ;
Miquel-Hebert, Karine ;
Serruys, Patrick W. .
EUROINTERVENTION, 2012, 7 (09) :1060-1061
[8]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441
[9]   Is the bioresorbable scaffold a sealing device? [J].
Gonzalo, Nieves ;
Escaned, Javier .
ATHEROSCLEROSIS, 2012, 221 (01) :36-37
[10]  
Latib A, J AM COLL C IN PRESS